Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy

Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy

Background: Sentinel lymph node biopsy (SLNB) has emerged as the standard procedure to replace axillary lymph node dissection (ALND) in breast cancer (BC) patients undergoing neo-adjuvant chemotherapy (NAC). SLNB is accepted in clinically node-negative (cN0) patients; however, its role in clinically...

Full description

Bibliographic Details
Main Authors: Corrado Tinterri, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Giulia Caraceni, Giacomo Ambrogi, Flavia Jacobs, Ersilia Biondi, Lorenzo Scardina, Damiano Gentile
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
sentinel lymph node biopsy
breast cancer
neo-adjuvant chemotherapy
surgery
Online Access:https://www.mdpi.com/2072-6694/15/6/1719

Internet

https://www.mdpi.com/2072-6694/15/6/1719

Similar Items